sage in the hills
08 Jan 2018
Why the fall on RNS ? .......dont understand ?Extra revenue and profit ....SAGE
cashpharma
29 Sep 2017
Re: share grants You're not very good at logical argument are you?Unsupported assertions leading to bizarre conclusions served up with a dollop of bile.
axolotl
29 Sep 2017
Re: share grants Don't be silly cashpharma, of course I approve, I was merely pointing out that for you to be consistent you would need to disapprove. I'm sorry if it's all too complicated for you to understand.
cashpharma
29 Sep 2017
Re: share grants If you don't approve of private investing and people risking capital to earn a return why are you posting on here?
axolotl
27 Sep 2017
Re: share grants Oh cashpharma, you virtue-signalling success-envying paragon of perfection. Gorged on sour grapes you loathe the people who work hard to be successful. So what exactly is it that you do to make money? Gamble on the stockmarket and sit on the moral high ground of your winnings gazing down at people who are worth more than you? If you pop down to Brighton today you can meet your soul-mates, Corbyn, McDonnell and McCluskey. You will be in your element.
cashpharma
26 Sep 2017
Re: share grants successful at what? signing contracts to buy additional earnings streams funded by cheap debt?I appreciate Micro focus management have done rather more than that in the past but £190m?
axolotl
26 Sep 2017
Re: share grants Yes cashpharma, they are thinking of voting Labour because they would rather ruin the economy for everyone than have any successful people to envy
cashpharma
26 Sep 2017
share grants £190m of share options?nice work if you can get it.no wonder people are thinking of voting Labour.
picstloup
18 Sep 2017
Should I stay or should I go? Having bought some Hewlett-Packard shares in January 2013 at $7.70, I find myself the unexpected owner of a few of these, roughly 10% of my total HP and spin off shares (45% HPQ, 30% HPE and 15% something called DXC).Probably I ought to flog off the MCROs and DXCs, but they're both showing heavy capital gains (plus fx gains), I'm already over my limit for this year and I hate paying CGT. Another alternative would be to top up these to make a worthwhile holding, as I did with Indivior when it was spun out of RB, and Zoetis from Pfizer. But I don't really fancy topping up on a FTSE100 company I'd not heard of before last month, although the 3% yield is respectable.Decisions, decisions.
II Editor
06 Sep 2017
NEW ARTICLE: Micro Focus rockets on HPE surprise "It's taken some time for the market to digest LSE:MCRO:Micro Focus's purchase of Hewlett Packard Enterprise's (HPE) software business. In fact, many analysts still appear to struggle getting to grips with HPE's figures, principally volatility of ..."[link]
Ripley94
02 Sep 2017
Re: Another cash return and consolidation 23/7/17. 10/05/17 . 22/06/16 ..Makes record keeping a little more complicated .
Rhigos
31 Aug 2017
Another cash return and consolidation Expected to place 15 Sep 2017 Share consolidation. 0.926303087067064 new shares for every existing share held. Cash return GBP1.68028953 per share.7.39% on current SP but consolidation will make number of shares you holding about 7.4% less so shareholders will not be any worse or better off but will have less cash invested in MCRO and similar amount of extra cash in your account. See RNS for details.
Ripley94
23 Jul 2017
Re: Micro Focus International infographi... Thank you Rhigos.Can see now it was wizard parent LLC... A Private company , part owned by the more familiar elliott management group ( USA ) .They sold @ 1505 p ..to raise 362 million .Looks like they sold to soon , even with recent pull back now 2200p ( 50 % more )
IB Investor
14 Jul 2017
Re: Exceptional costs Hopefully not - working for a company in the past who acquired other software companies ( 50 in one year at one point) and who had the practice down pat - their share price doubled every 3 years. Not suggesting this will happen here, but hoping it is a good move, and the fall is a blip. Lots of synergies from these situations. Opportunity to top up
cashpharma
13 Jul 2017
Exceptional costs Wow look at those exceptional costs. Beginning of a long chain of shareholder value destruction i suspect.Imagine how much is gonna be spent after the deal goes through with no certainty as to the outcome. High risk share best avoided.
